Level of Evidence Summary: Diabetic Peripheral Neuropathy: Moderate ([1][6]) Peripheral Neuropathic Pain (General): Moderate[11] Fibromyalgia: Low to Moderate[7][8][9] Central Sensitization/Nociplastic Pain: Low to Moderate (Strong mechanistic rationale
"The Role of Glucagon-like Peptide-1 in Reproduction: From Physiology to Therapeutic Perspective." Human Reproduction Update , vol
How is Ozempic different from other GLP-1 drugs
Inositol, specifically the combination of myo-inositol and D-chiro-inositol, is well-studied for women with PCOS-related weight struggles
Further Reading Book: Michael Greger, Ozempic: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs (2024)
[Sidebar discussion: is there a market to develop products and services for the longevity economy to meet the needs of people who are less affluent, older, etc